CVS Health Corp (CVS)

CVS Health’s latest quarter saw the company deliver revenue and profit above Wall Street’s expectations, but the market responded negatively. Management poin...

Divesting the company's business units into smaller segments could have significant implications.

CVS Health (NYSE:CVS) plans to separate its retail pharmacy operations from its insurance and pharmacy services businesses, creating two publicly traded companies in a transaction expected to close in the first half of 2028. The announcement came as the company reported third-quarter 2026 revenue o

Management unveils a plan to split the company into two public businesses.

Diversified healthcare company CVS Health (NYSE:CVS) reported revenue ahead of Wall Street’s expectations in Q3 2026, with revenue up 5.4% year on year to $1...

Diversified healthcare company CVS Health (NYSE:CVS) will be reporting results this Wednesday before market open. Here’s what you need to know. CVS Health be...

Alphabet's 12% drop followed search and YouTube misses as Google Cloud beat. Altimetry likes Microsoft, AMD and Generac and avoids CoreWeave and Cipher Digital.

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...

CVS Health stock is down 16% from its 52-week high, and it trades at a relatively modest valuation.

Treasuries pay more today, but these three healthcare dividend payers offer something Treasuries can't: growth in both the payout and the stock.

Income investors now have a choice they haven't had to make in nearly two decades.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how health insurance provi...

CVS Health is looking more attractive -- and it sports an appealing dividend, too, recently yielding 2.8%.

CVS Health (NYSE:CVS) executives said the company is seeing improved momentum across its insurance, pharmacy, care delivery and balance-sheet priorities, while maintaining a cautious outlook on healthcare cost trends and several 2027 headwinds. Speaking at an investor conference, Chief Financial Of